Skip to content

Clinical trials

Terminated Hyperparathyroidism, Secondary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperparathyroidism, Secondary Status: Terminated Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20072
20081
20091
20102
20111
20123
20141
20201
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
AbbVie1
AbbVie (prior sponsor, Abbott)1
Abbott1
Emory University1
KAI Pharmaceuticals1
Montefiore Medical Center1
OPKO Health, Inc.1
Papageorgiou General Hospital1
Per Ivarsen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperparathyroidism, Secondary15
Renal Insufficiency, Chronic7
Vitamin D Deficiency3
Chronic Kidney Disease-Mineral and Bone Disorder2
Hypercalcemia2
Hyperparathyroidism2
Kidney Failure, Chronic2
Coronary Artery Disease1
Hyperphosphatemia1
Hypertrophy, Left Ventricular1

Trials

Showing 51 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.